Vaccine makers’ shares jump after bird flu death in US
Moderna, Pfizer, CureVac and Novavax register gains as CDC stresses risk to public ‘remains low’
Moderna, Pfizer, CureVac and Novavax register gains as CDC stresses risk to public ‘remains low’